Literature DB >> 27382077

Health-Care Workers' Perspectives on Ebola Virus Vaccine: A Focus Group and In-Depth Interview Interventional Study.

Dorothy O Esangbedo1, Maduka D Ughasoro2, Beckie N Tagbo3, Adebiyi Olowu4, Chukwuemeka Anikene5, Chimaobi C Iwegbulam6.   

Abstract

Health-care workers (HCWs) will require Ebola virus vaccine (EVV) when it is introduced because of the high risk of exposure to the disease. Evaluations of factors that facilitate or limit vaccine uptake are critical for a successful vaccine program. Nigerian HCWs were interviewed to evaluate their knowledge, levels of acceptance, determinants of acceptance, and willingness to pay for EVV. The significance level was set at P ≤ 0.05. None of the 193 participating HCWs had correct knowledge of EVV; 34.7% (67/193) of workers thought that EVV was an extract of the serum of Ebola virus patients. About 77.3% (51/66) of workers in a region that reported Ebola cases (Lagos) were willing to be vaccinated, compared with 4.7% (3/61) in Enugu and 13.6% (9/66) in Abia (P = 0.0001). After health education, the proportion of HCWs willing to receive EVV increased (P = 0.006) except for doctors (P < 0.1). The percentage of HCWs willing to pay for EVV was 86.4%, 72.1%, and 59% in Lagos, Enugu, and Abia, respectively. The workers had fears about EVV based on nonfactual assumptions. Therefore, the EVV introduction strategy should include a strong awareness campaign with adequate explanation about the content of EVV. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27382077      PMCID: PMC5014274          DOI: 10.4269/ajtmh.16-0206

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Seeking health information: what sources do your patients use?

Authors:  Carolyn Crane Cutilli
Journal:  Orthop Nurs       Date:  2010 May-Jun       Impact factor: 0.913

2.  Determinants of intention to get vaccinated against novel (pandemic) influenza A H1N1 among health-care workers in a nationwide survey.

Authors:  Helena C Maltezou; Xanthi Dedoukou; Stavros Patrinos; Antonios Maragos; Sophia Poufta; Panagiotis Gargalianos; Marios Lazanas
Journal:  J Infect       Date:  2010-06-17       Impact factor: 6.072

Review 3.  A systematic review of factors influencing older adults' decision to accept or decline cancer treatment.

Authors:  Martine T E Puts; Brianne Tapscott; Margaret Fitch; Doris Howell; Johanne Monette; Doreen Wan-Chow-Wah; Monika Krzyzanowska; Nathasha B Leighl; Elena Springall; Shabbir M Alibhai
Journal:  Cancer Treat Rev       Date:  2014-12-26       Impact factor: 12.111

4.  Sources of health information related to preventive health behaviors in a national study.

Authors:  Nicole Redmond; Heather J Baer; Cheryl R Clark; Stuart Lipsitz; LeRoi S Hicks
Journal:  Am J Prev Med       Date:  2010-06       Impact factor: 5.043

5.  Economic evaluation of the routine childhood immunization program in the United States, 2009.

Authors:  Fangjun Zhou; Abigail Shefer; Jay Wenger; Mark Messonnier; Li Yan Wang; Adriana Lopez; Matthew Moore; Trudy V Murphy; Margaret Cortese; Lance Rodewald
Journal:  Pediatrics       Date:  2014-03-03       Impact factor: 7.124

6.  Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Authors:  Ana Maria Henao-Restrepo; Ira M Longini; Matthias Egger; Natalie E Dean; W John Edmunds; Anton Camacho; Miles W Carroll; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Stefanie Hossmann; Mandy Kader Kondé; Souleymane Kone; Eeva Kuisma; Myron M Levine; Sema Mandal; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; Conall H Watson; Sakoba Kéïta; Marie Paule Kieny; John-Arne Røttingen
Journal:  Lancet       Date:  2015-08-03       Impact factor: 79.321

7.  Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys.

Authors:  Josette S Y Chor; Karry L K Ngai; William B Goggins; Martin C S Wong; Samuel Y S Wong; Nelson Lee; Ting-fan Leung; Timothy H Rainer; Sian Griffiths; Paul K S Chan
Journal:  BMJ       Date:  2009-08-25

8.  Are the poor differentially benefiting from provision of priority public health services? A benefit incidence analysis in Nigeria.

Authors:  Obinna Onwujekwe; Kara Hanson; Benjamin Uzochukwu
Journal:  Int J Equity Health       Date:  2012-11-16

9.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

10.  Ebolavirus in West Africa, and the use of experimental therapies or vaccines.

Authors:  Thomas Hoenen; Heinz Feldmann
Journal:  BMC Biol       Date:  2014-09-26       Impact factor: 7.431

View more
  6 in total

1.  Health-Care Workers' Perspectives on Preparedness of Health-Care Facilities for Outbreak of Communicable Diseases in Nigeria: A Qualitative Study.

Authors:  Maduka D Ughasoro; Dorothy O Esangbedo; Ifechukwu Maria Udorah
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

2.  Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.

Authors:  Mohamed F Jalloh; Mohammad B Jalloh; Alison Albert; Brent Wolff; Amy Callis; Aparna Ramakrishnan; Emily Cramer; Paul Sengeh; Samuel Abu Pratt; Lansana Conteh; Rana Hajjeh; Rebecca Bunnell; John T Redd; Anna Mia Ekström; Helena Nordenstedt
Journal:  Vaccine       Date:  2019-02-10       Impact factor: 3.641

Review 3.  Considerations for use of Ebola vaccine during an emergency response.

Authors:  Jenny A Walldorf; Emily A Cloessner; Terri B Hyde; Adam MacNeil
Journal:  Vaccine       Date:  2017-09-07       Impact factor: 3.641

4.  Willingness to pay for an Ebola vaccine during the 2014-2016 ebola outbreak in West Africa: Results from a U.S. National sample.

Authors:  Julia E Painter; Michael E von Fricken; Suyane Viana de O Mesquita; Ralph J DiClemente
Journal:  Hum Vaccin Immunother       Date:  2018-02-15       Impact factor: 3.452

5.  Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh.

Authors:  Mudatsir Mudatsir; Samsul Anwar; Jonny K Fajar; Amanda Yufika; Muhammad N Ferdian; Salwiyadi Salwiyadi; Aga S Imanda; Roully Azhars; Darul Ilham; Arya U Timur; Juwita Sahputri; Ricky Yordani; Setia Pramana; Yogambigai Rajamoorthy; Abram L Wagner; Kurnia F Jamil; Harapan Harapan
Journal:  F1000Res       Date:  2019-08-15

6.  Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China.

Authors:  Tao-Hsin Tung; Xiao-Qing Lin; Yan Chen; Hongwei Wu; Mei-Xian Zhang; Jian-Sheng Zhu
Journal:  Hum Vaccin Immunother       Date:  2022-01-21       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.